SCHEMBL6722304

SCHEMBL6722304

CCOC(=O)C(Cc1ccc(OCCOS(C)(=O)=O)cc1)Oc1ccc(C(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 10/20 0.45
PPARG P37231 10/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.39
PPARD Q03181 2/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA9 Q16790 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718054 0.89 PPARG (0.50) PPARAPPARGL3MBTL1TDP1LMNA
SCHEMBL6713392 0.88 PPARG (0.48) PPARAPPARGL3MBTL1TDP1PPARD
SCHEMBL6713389 0.85 L3MBTL1 (0.47) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL6713327 0.84 L3MBTL1 (0.46) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL6715218 0.81 L3MBTL1 (0.48) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL6715217 0.78 OPRK1 (0.45) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL6716277 0.77 CA12 (0.47) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL6713421 0.77 KMT2A (0.47) PPARAPPARGL3MBTL1NPC1RAB9A
SCHEMBL27297551 0.75 PPARA (0.50) PPARAPPARGMEN1KMT2APPARD
SCHEMBL29928782 0.75 PPARA (0.50) PPARAPPARGMEN1KMT2APPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARA 71/4885PPARG 23/4885L3MBTL1 1431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.